by Elio
Cholesterol and MRSAs vie for headlines. Both are formidable topics of enormous interest to readers of mass media and to scientists (many of whom read mass media, probably in the bathroom). It turns out that Staphylococcus aureus and arteriosclerosis have something in common, although not in the way you might think. It happens that the yellowish-golden pigment of S. aureus is made by a pathway that, in its early steps, resembles the one for making steroids.
Let’s back up a moment. The S. aureus pigment is a carotenoid called staphyloxanthin. Although the discoverer of the organism, the Scottish surgeon Alexander Ogston, coined its species name in 1880, the role of the pigment has only been recently uncovered. It is essential for the virulence of the organism, acting as an antioxidant that detoxifies host-produced reactive oxygen species, such as O2–, ·OH, and HOCl. Mutants lacking the pigment are much less virulent. Sounds like blocking the synthesis of staphyloxanthin would be a good way to combat staph infections, no?

The pathways for making staphyloxanthin and steroids. Source















